Brazilian Journal of Infectious Diseases (Jul 2015)

Disease burden of chronic hepatitis C in Brazil

  • Paulo Roberto Abrão Ferreira,
  • Carlos Eduardo Brandão-Mello,
  • Chris Estes,
  • Fernando Lopes Gonçales Júnior,
  • Henrique Sérgio Moraes Coelho,
  • Homie Razavi,
  • Hugo Cheinquer,
  • Fernando Herz Wolff,
  • Maria Lúcia Gomes Ferraz,
  • Mário Guimarães Pessoa,
  • Maria Cássia Mendes-Correa

Journal volume & issue
Vol. 19, no. 4
pp. 363 – 368

Abstract

Read online

Background: Hepatitis C virus infection is a major cause of cirrhosis; hepatocellular carcinoma; and liver transplantation. The aim of this study was to estimate hepatitis C virus disease progression and the burden of disease from a nationwide perspective. Methods: Using a model developed to forecast hepatitis C virus disease progression and the number of cases at each stage of liver disease; hepatitis C virus-infected population and associated disease progression in Brazil were quantified. The impact of two different strategies was compared: higher sustained virological response and treatment eligibility rates (1) or higher diagnosis and treatment rates associated with increased sustained virological response rates (2). Results: The number of infected individuals is estimated to decline by 35% by 2030 (1,255,000 individuals); while the number of cases of compensated (n = 325,900) and decompensated (n = 45,000) cirrhosis; hepatocellular carcinoma (n = 19,100); and liver-related deaths (n = 16,700) is supposed to peak between 2028 and 2032. In strategy 2; treated cases increased over tenfold in 2020 (118,800 treated) as compared to 2013 (11,740 treated); with sustained virological response increased to 90% and treatment eligibility to 95%. Under this strategy; the number of infected individuals decreased by 90% between 2013 and 2030. Compared to the base case; liver-related deaths decreased by 70% by 2030; while hepatitis C virus-related liver cancer and decompensated cirrhosis decreased by 75 and 80%; respectively. Conclusions: While the incidence and prevalence of hepatitis C virus in Brazil are decreasing; cases of advanced liver disease continue to rise. Besides higher sustained virological response rates; new strategies focused on increasing the proportion of diagnosed patients and eligibility to treatment should be adopted in order to reduce the burden of hepatitis C virus infection in Brazil. Keywords: HCV, Disease burden, Epidemiology, Incidence, Brazil